On the other hand, tumours associated with BRCA2 mutations are of a luminal subtype, and tend to be of a positive oestrogen and progesterone receptors-status; negative HER-2, on the other hand, do not markedly differ from other hereditary or sporadic breast cancers[14]. Here, ERBB2 is linked to breast carcinoma.